Myelodysplastic Syndrome
Myelodysplastic syndrome (MDS) is a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis and a risk of progression to acute myeloid leukemia (AML).
MDS treatment
Myelodysplastic Syndrome with 5q Deletion (del(5q) MDS)
Myelodysplastic syndrome with 5q deletion (del(5q) MDS) is a distinct subtype of myelodysplastic syndromes (MDS) characterized by a deletion in the long arm of chromosome
Myelodysplastic Syndrome (MDS)
Myelodysplastic syndrome (MDS) is a group of hematologic disorders characterized by ineffective blood cell production due to bone marrow dysfunction. This leads to cytopenias, increasing